Telmisartan Benzimidazole Acid CAS 152628-03-0 Purity >99.5% (HPLC) Telmisartan Intermediate 3 Factory
Ruifu Chemical Supply Telmisartan Intermediates With High Purity
Telmisartan CAS 144701-48-4
Methyl 2-(p-Tolyl)benzoate CAS 114772-34-8
2-(p-Tolyl)benzoic Acid CAS 7148-03-0
Telmisartan Benzimidazole Acid CAS 152628-03-0
Telmisartan Methyl Ester CAS 528560-93-2
Methyl 2-[4-(Bromomethyl)phenyl]benzoate CAS 114772-38-2
Methyl 4-(Butyrylamino)-3-Methyl-5-Nitrobenzoate CAS 152628-01-8
2-n-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-yl)benzimidazole CAS 152628-02-9
Chemical Name | 4-Methyl-2-Propyl-6-Benzimidazolecarboxylic Acid |
Synonyms | Telmisartan Benzimidazole Acid; Telmisartan Intermediate 3; 4-Methyl-2-n-Propyl-1H-Benzimidazole-6-Carboxylic Acid; 2-n-Propyl-4-Methyl-6-Carboxylate-1H-Benzimidazole; 1H-Benzimidazole-4-Methyl-2-Propyl-6-Carboxylic Acid; 7-Methyl-2-Propyl-1H-Benzimidazole-5-Carboxylic Acid |
CAS Number | 152628-03-0 |
CAT Number | RF-PI1880 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C12H14N2O2 |
Molecular Weight | 218.26 |
Melting Point | 300℃(lit.) |
Density | 1.259±0.06 g/cm3 |
Solubility | Soluble in DMSO and Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Powder |
Identification (HPLC) | Must Conform to Reference Standard |
Purity / Analysis Method | >99.5% (HPLC) |
Water (by Karl Fischer) | <0.50% |
Residue on Ignition | <0.20% |
Any Single Impurity | <0.50% |
Total Impurities | <0.50% |
Heavy Metals | <20ppm |
Proton NMR Spectrum | Conforms to Structure |
Test Standard | Enterprise Standard |
Usage | Intermediate of Telmisartan (CAS: 144701-48-4) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
4-Methyl-2-Propyl-6-Benzimidazolecarboxylic Acid, also known as Telmisartan Benzimidazole Acid (CAS: 152628-03-0) is an important intermediate of Telmisartan (CAS: 144701-48-4). Telmisartan is a potent, long lasting, non-peptide AT1 angiotensin receptor antagonist indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Cardiovascular (CV) risk reduction in patients unable to take ACE inhibitors. Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart.